Abstract
Purpose:
To systematically review and meta-analyze the efficacy of photobiomodulation therapy (PBMT) for temporomandibular disorders (TMDs), focusing on the influence of intensity, frequency, and duration on pain reduction and functional improvement.
Methods:
Through a systematic search of PubMed, Cochrane, and EMBASE, we identified randomized controlled trials (RCTs) involving adults with TMD who were treated with PBMT. Ultimately, 40 RCTs were included, and a meta-analysis was conducted using Review Manager 5.4. The primary outcomes included pain, pain-free opening (PFO), maximum-unassisted opening, and maximum-assisted opening (MAO).
Results:
PBMT significantly reduced pain at the third assessment (T2). The optimal parameters included wavelengths (951–1070 nm) and output power (below 100 mW). Additionally, PFO and MAO significantly improved at T2. Treatment durations exceeding 10 weeks were most effective for articular–muscular TMDs, whereas shorter durations were more beneficial for purely articular or muscular TMDs. Three to four sessions per week yielded the best outcomes.
Conclusion:
Effective pain reduction was achieved with high wavelengths (951–1070 nm), low power (<100 mW), and frequent, long-term treatment (3–4 times per week over 10 weeks). Avoiding high energy consumption over a short period was crucial. This approach is more effective for articular–muscular TMDs than for purely articular or muscular conditions.
Keywords
Get full access to this article
View all access options for this article.
